Literature DB >> 14967718

Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction.

Leonardo Bolognese1, Nazario Carrabba, Guido Parodi, Giovanni M Santoro, Piergiovanni Buonamici, Giampaolo Cerisano, David Antoniucci.   

Abstract

BACKGROUND: We hypothesized that preserved microvascular integrity in the area at risk would favorably influence left ventricular (LV) remodeling and long-term outcome after acute myocardial infarction. METHODS AND
RESULTS: Before and after successful primary angioplasty (percutaneous transluminal coronary angioplasty [PTCA]), 124 patients with acute myocardial infarction underwent intracoronary myocardial contrast echo (MCE). An MCE score index (MCESI) was derived by averaging the single-segment score (0=not visible, 1=patchy, 2=homogeneous contrast effect) within the area at risk. An MCESI > or =1 was considered adequate reperfusion. Mean follow-up was 46+/-32 months. After PTCA, 100 patients showed adequate reperfusion (no microvascular dysfunction, NoMD), whereas 24 did not (MD). MD patients had a higher mean creatine kinase (4153+/-2422 versus 2743+/-1774 U/L; P=0.002) and baseline wall-motion score index (2.61+/-0.31 versus 2.25+/-0.42; P<0.001) and a lower baseline ejection fraction (33+/-8% versus 40+/-7%; P<0.001). From day 1 on, LV volumes progressively increased in the MD patients (n=19) and were larger than those of NoMD patients (n=85) at 6 months (end-diastolic volume 170+/-55 versus 115+/-29 mL; P<0.001). MCESI was the most important independent predictor of LV dilation (OR 0.61, 95% CI 0.52 to 0.71, P<0.000001). By Cox analysis, MD represented the only predictor of cardiac death (OR 0.26, 95% CI 0.09 to 0.72, P=0.010) and combined events (cardiac death, reinfarction, and heart failure; OR 0.44, 95% CI 0.23 to 0.85, P=0.014). MD patients showed worse survival in terms of cardiac death (P<0.0001) and combined events (P<0.0001).
CONCLUSIONS: In reperfused acute myocardial infarction, MD within the risk area is an important predictor of both LV remodeling and unfavorable long-term outcome.

Entities:  

Mesh:

Year:  2004        PMID: 14967718     DOI: 10.1161/01.CIR.0000118496.44135.A7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  96 in total

1.  Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model.

Authors:  Stavros Stavrakis; John Terrovitis; Elias Tsolakis; Stavros Drakos; Argirios Dalianis; Michael Bonios; Dimitrios Koudoumas; Konstantinos Malliaras; John Nanas
Journal:  J Cardiovasc Transl Res       Date:  2010-12-09       Impact factor: 4.132

2.  Left ventricular remodeling in the elderly with acute anterior myocardial infarction treated with primary coronary intervention.

Authors:  Francesca Innocenti; Francesca Caldi; Cinzia Meini; Chiara Agresti; Giorgio J Baldereschi; Niccolò Marchionni; Giulio Masotti; Riccardo Pini
Journal:  Intern Emerg Med       Date:  2010-07-17       Impact factor: 3.397

3.  Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Authors:  Ann C Gaffey; Minna H Chen; Chantel M Venkataraman; Alen Trubelja; Christopher B Rodell; Patrick V Dinh; George Hung; John W MacArthur; Renganaden V Soopan; Jason A Burdick; Pavan Atluri
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-17       Impact factor: 5.209

4.  Value of the myocardial performance index in myocardial infarction.

Authors:  L Galiuto
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.

Authors:  Vladimír Dzavík; Christopher E Buller; Gervasio A Lamas; James M Rankin; G B John Mancini; Warren J Cantor; Ronald J Carere; John R Ross; Deborah Atchison; Sandra Forman; Boban Thomas; Pawel Buszman; Carlos Vozzi; Anthony Glanz; Eric A Cohen; Peter Meciar; Gerald Devlin; Alice Mascette; George Sopko; Genell L Knatterud; Judith S Hochman
Journal:  Circulation       Date:  2006-11-14       Impact factor: 29.690

6.  Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.

Authors:  Dennis T L Wong; Michael C H Leung; James D Richardson; Rishi Puri; Angela G Bertaso; Kerry Williams; Ian T Meredith; Karen S L Teo; Matthew I Worthley; Stephen G Worthley
Journal:  Int J Cardiovasc Imaging       Date:  2012-02-05       Impact factor: 2.357

Review 7.  Future directions of myocardial fatty acid imaging.

Authors:  Christopher J Pastore; John W Babich; James E Udelson
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 8.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

9.  Contrast echocardiography accurately predicts myocardial perfusion before angiography during acute myocardial infarction.

Authors:  Gregory B Schnell; Albert J Kryski; Luana Mann; Todd J Anderson; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

Review 10.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.